FindTrial
Sign In

Management of anaesthesia for patients undergoing mucormycosis surgery

Anaesthetic management of patients coming for mucormycosis surgery: A prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036211
Enrollment
40
Registered
2021-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U072- COVID 19 virus not identified

Interventions

None listed

Sponsors

Supreeth R Shetty
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients requiring anaesthesia for debridement of rhinocerebral mucormycosis. 2. Patients willing to participate.

Exclusion criteria

Exclusion criteria: 1.Patient refusal

Design outcomes

Primary

MeasureTime frame
TO assess mortality and morbidity like need for ICU stay, mechanical ventilation after surgeryTimepoint: 0 hours after extubation 24 hours after end of surgery—

Secondary

MeasureTime frame
difficulty in airway management, blood loss, blood transfusion requirement, surgical complications, airway complications.Timepoint: upto 24 hours postoperatively—

Countries

India

Contacts

Public ContactSupreeth R Shetty

SDM College of Medical Sciences and Hospital

supreethrshetty@gmail.com9945619565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026